CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Inhibitory Effect of Rosae Multiflorae Fructus Extracts on the Receptor Activator of NF-κB Ligand-Induced Osteoclastogenesis through Modulation of P38- and Ca2+-Mediated Nuclear Factor of Activated T-Cells Cytoplasmic 1 Express
Keun Ha Park, Dong Ryun Gu, Min Seuk Kim, Seoung Hoon Lee
jbm. 2020;27(1):53-63.   Published online February 29, 2020
DOI: https://doi.org/10.11005/jbm.2020.27.1.53

Excel Download

Inhibitory Effect of Rosae Multiflorae Fructus Extracts on the Receptor Activator of NF-κB Ligand-Induced Osteoclastogenesis through Modulation of P38- and Ca2+-Mediated Nuclear Factor of Activated T-Cells Cytoplasmic 1 Expression
Journal of Bone Metabolism. 2020;27(1):53   Crossref logo
Link1 Link2 Link3

Inhibitory activity of linarin on osteoclastogenesis through receptor activator of nuclear factor κB ligand-induced NF-κB pathway
Biochemical and Biophysical Research Communications. 2018;495(3):2133-2138   Crossref logo
Link1 Link2

Simvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor-κB ligand through modulation of NF-κB pathway
International Journal of Cancer. 2008;123(8):1733-1740   Crossref logo
Link1 Link2

Involvement of p38 Mitogen-activated Protein Kinase Signaling Pathway in Osteoclastogenesis Mediated by Receptor Activator of NF-κB Ligand (RANKL)
Journal of Biological Chemistry. 2000;275(40):31155-31161   Crossref logo
Link1 Link2 Link3

WITHDRAWN: Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand
Cancer Letters. 2011;   Crossref logo
Link1 Link2

Isofraxidin Inhibits Receptor Activator of Nuclear Factor-κB Ligand–Induced Osteoclastogenesis in Bone Marrow–Derived Macrophages Isolated from Sprague–Dawley Rats by Regulating NF-κB/NFATc1 and Akt/NFATc1 Signaling Pathways
Cell Transplantation. 2021;30:096368972199032   Crossref logo
Link1 Link2 Link3

HIV Envelope gp120-mediated Regulation of Osteoclastogenesis via Receptor Activator of Nuclear Factor κB Ligand (RANKL) Secretion and Its Modulation by Certain HIV Protease Inhibitors through Interferon-γ/RANKL Cross-talk
Journal of Biological Chemistry. 2003;278(48):48251-48258   Crossref logo
Link1 Link2 Link3

Resveratrol-mediated SIRT-1 Interactions with p300 Modulate Receptor Activator of NF-κB Ligand (RANKL) Activation of NF-κB Signaling and Inhibit Osteoclastogenesis in Bone-derived Cells
Journal of Biological Chemistry. 2011;286(13):11492-11505   Crossref logo
Link1 Link2 Link3

Fexaramine Inhibits Receptor Activator of Nuclear Factor-κB Ligand-induced Osteoclast Formation via Nuclear Factor of Activated T Cells Signaling Pathways
Journal of Bone Metabolism. 2017;24(4):207   Crossref logo
Link1 Link2 Link3

Aconitum pseudo-laeve var. erectum Inhibits Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Osteoclastogenesis via the c-Fos/nuclear Factor of Activated T-Cells, Cytoplasmic 1 Signaling Pathway and Prevents Lipopolysaccharide-Induced Bone Loss in Mice
Molecules. 2014;19(8):11628-11644   Crossref logo
Link1